About Us QuitPak Catheter Lock Our Team For Investors

Cary Pharmaceuticals is a pharmaceutical development company. The Company is advancing the development of QuitPak®, a patented treatment for smoking cessation, and a novel catheter lock solution to prevent clot formation in catheters. The Company is led by an experienced management team and Board of Directors, including Douglas Cary (President), a former Abbott Laboratories executive; Carl Schwan (CFO), a former CFO for two successful initial public offerings that raised $80 million; and Lester Crawford (Director), Former Commissioner of the U.S. Food and Drug Administration (FDA)

Cary Pharmaceuticals Inc.
9903 Windy Hollow Road
Great Falls, Virginia 22066

Phone: (703) 759-7460